The COVID-19 pandemic has raised novel ethical issues and intensified existing ones in clinical research. From the abundance of ethical issues, the MRCT Center identified 3 topics to initiate discussion at the June 1st Bioethics Collaborative: 1) clinical equipoise and the standard-of-care for COVID-19 research, 2) clinical trial prioritization amidst a scarcity of resources, and 3) the role of the Institutional Review Board in COVID-19 research. Attendees guided discussion beyond these issues over the course of the Bioethics Collaborative.
September 2022: Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19
February 2021: An Ethics Framework for Consolidating and Prioritizing COVID-19 Clinical Trials
November 2020: Ethical Challenges in Clinical Research During the COVID-19 Pandemic
August 2020: The Decision to Enroll in a Clinical Trial Should Be Unencumbered